SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Michaela Dostalova Merkerova, Zdenek Krejcik, Monika Belickova, Andrea Hrustincova, Jiri Klema, Eliška Stara, Zuzana Zemanova, Kyra Michalova, Jaroslav Cermak, Anna Jonasova, Genome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomide, European Journal of Haematology, 2015, 94, 3
  2. 2
    Andrea Pellagatti, Jacqueline Boultwood, The molecular pathogenesis of the myelodysplastic syndromes, European Journal of Haematology, 2015, 94, 3
  3. 3
    Stef Meers, The myelodysplastic syndromes: the era of understanding, European Journal of Haematology, 2015, 94, 3
  4. 4
    Aristoteles Giagounidis, Ghulam J. Mufti, Pierre Fenaux, Ulrich Germing, Alan List, Kyle J. MacBeth, Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes, Annals of Hematology, 2014, 93, 1, 1

    CrossRef

  5. 5
    Mahmoud R. Gaballa, Emmanuel C. Besa, Myelodysplastic syndromes with 5q deletion: pathophysiology and role of lenalidomide, Annals of Hematology, 2014, 93, 5, 723

    CrossRef

  6. 6
    David A. Sallman, Sheng Wei, Alan List, PP2A: The Achilles Heal in MDS with 5q Deletion, Frontiers in Oncology, 2014, 4,

    CrossRef

  7. 7
    Rebekka K. Schneider, Vera Ademà, Dirk Heckl, Marcus Järås, Mar Mallo, Allegra M. Lord, Lisa P. Chu, Marie E. McConkey, Rafael Kramann, Ann Mullally, Rafael Bejar, Francesc Solé, Benjamin L. Ebert, Role of Casein Kinase 1A1 in the Biology and Targeted Therapy of del(5q) MDS, Cancer Cell, 2014, 26, 4, 509

    CrossRef

  8. 8
    B H Yip, C Vuppusetty, M Attwood, A Giagounidis, U Germing, A A Lamikanra, D J Roberts, J P Maciejewski, P Vandenberghe, C Mecucci, J S Wainscoat, A Pellagatti, J Boultwood, Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts, Leukemia, 2013, 27, 8, 1760

    CrossRef

  9. 9
    Esther Natalie Oliva, Maria Cuzzola, Maria Antonietta Aloe Spiriti, Antonella Poloni, Carmelo Laganà, Carmela Rigolino, Fortunato Morabito, Sara Galimberti, Riccardo Ghio, Agostino Cortelezzi, Giuseppe Alberto Palumbo, Grazia Sanpaolo, Carlo Finelli, Alessandra Ricco, Antonio Volpe, Filippo Rodà, Massimo Breccia, Giuliana Alimena, Francesco Nobile, Roberto Latagliata, Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study, Annals of Hematology, 2013, 92, 1, 25

    CrossRef

  10. 10
    Rami S. Komrokji, Eric Padron, Benjamin L. Ebert, Alan F. List, Deletion 5q MDS: Molecular and therapeutic implications, Best Practice & Research Clinical Haematology, 2013, 26, 4, 365

    CrossRef

  11. 11
    Lingyun Wu, Xiao Li, Feng Xu, Zheng Zhang, Chunkang Chang, Qi He, Low RPS14 expression in MDS without 5q - aberration confers higher apoptosis rate of nucleated erythrocytes and predicts prolonged survival and possible response to lenalidomide in lower risk non-5q- patients, European Journal of Haematology, 2013, 90, 6
  12. 12
    R. Coleman Lindsley, Benjamin L. Ebert, Molecular Pathophysiology of Myelodysplastic Syndromes, Annual Review of Pathology: Mechanisms of Disease, 2013, 8, 1, 21

    CrossRef

  13. 13
    Mehmet A Özcan, Osman Ilhan, Osman I Ozcebe, Meliha Nalcaci, Zafer Gülbas, Review of therapeutic options and the management of patients with myelodysplastic syndromes, Expert Review of Hematology, 2013, 6, 2, 165

    CrossRef

  14. 14
    Antonella Poloni, Federica Serrani, Eleonora Berardinelli, Giulia Maurizi, Marianna Mariani, Benedetta Costantini, Silvia Trappolini, Stefania Mancini, Attilio Olivieri, Pietro Leoni, Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome, Leukemia Research, 2013, 37, 11, 1538

    CrossRef

  15. 15
    Radana Neuwirtova, Ota Fuchs, Monika Holicka, Martin Vostry, Arnost Kostecka, Hana Hajkova, Anna Jonasova, Jaroslav Cermak, Radek Cmejla, Dagmar Pospisilova, Monika Belickova, Magda Siskova, Ivana Hochova, Jana Vondrakova, Dana Sponerova, Eva Kadlckova, Ludmila Novakova, Jana Brezinova, Kyra Michalova, Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond–Blackfan anemia, Annals of Hematology, 2013, 92, 1, 11

    CrossRef

  16. 16
    Yanming Zhang, Janet D Rowley, Emery and Rimoin's Principles and Practice of Medical Genetics, 2013,

    CrossRef

  17. 17
    Ioannis A. Voutsadakis, Anne Cairoli, A critical review of the molecular pathophysiology of lenalidomide sensitivity in 5q − myelodysplastic syndromes, Leukemia & Lymphoma, 2012, 53, 5, 779

    CrossRef

  18. 18
    Jana Brezinova, Zuzana Zemanova, Dagmar Bystricka, Iveta Sarova, Libuse Lizcova, Eva Malinova, Silvia Izakova, Jana Sajdova, Dana Sponerova, Anna Jonasova, Jaroslav Cermak, Kyra Michalova, Deletion of the long arm but not the 5q31 region of chromosome 5 in myeloid malignancies, Leukemia Research, 2012, 36, 3, e43

    CrossRef

  19. 19
    G W Rhyasen, D T Starczynowski, Deregulation of microRNAs in myelodysplastic syndrome, Leukemia, 2012, 26, 1, 13

    CrossRef

  20. 20
    B H Yip, A Pellagatti, C Vuppusetty, A Giagounidis, U Germing, A A Lamikanra, D J Roberts, M Fernandez-Mercado, E-J McDonald, S Killick, J S Wainscoat, J Boultwood, Effects of L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts, Leukemia, 2012, 26, 9, 2154

    CrossRef

  21. 21
    Jacqueline Boultwood, Andrea Pellagatti, James S. Wainscoat, Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome, Advances in Biological Regulation, 2012, 52, 1, 196

    CrossRef

  22. 22
    Ota Fuchs, Important Genes in the Pathogenesis of 5q- Syndrome and Their Connection with Ribosomal Stress and the Innate Immune System Pathway, Leukemia Research and Treatment, 2012, 2012, 1

    CrossRef

  23. 23
    K. Hussein, Pathobiologie des microRNA-Systems, Der Pathologe, 2012, 33, 1, 70

    CrossRef

  24. 24
    Eric Padron, Rami Komrokji, Alan F List, Biology and treatment of the 5q- syndrome, Expert Review of Hematology, 2011, 4, 1, 61

    CrossRef

  25. 25
    L. Malcovati, E. Papaemmanuil, D. T. Bowen, J. Boultwood, M. G. Della Porta, C. Pascutto, E. Travaglino, M. J. Groves, A. L. Godfrey, I. Ambaglio, A. Galli, M. C. Da Via, S. Conte, S. Tauro, N. Keenan, A. Hyslop, J. Hinton, L. J. Mudie, J. S. Wainscoat, P. A. Futreal, M. R. Stratton, P. J. Campbell, E. Hellstrom-Lindberg, M. Cazzola, Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms, Blood, 2011, 118, 24, 6239

    CrossRef

  26. 26
    C. C. Wong, D. Traynor, N. Basse, R. R. Kay, A. J. Warren, Defective ribosome assembly in Shwachman-Diamond syndrome, Blood, 2011, 118, 16, 4305

    CrossRef

  27. 27
    Michaela Dostalova Merkerova, Zdenek Krejcik, Hana Votavova, Monika Belickova, Alzbeta Vasikova, Jaroslav Cermak, Distinctive microRNA expression profiles in CD34+ bone marrow cells from patients with myelodysplastic syndrome, European Journal of Human Genetics, 2011, 19, 3, 313

    CrossRef

  28. 28
    K Theilgaard-Mönch, J Boultwood, S Ferrari, K Giannopoulos, J M Hernandez-Rivas, A Kohlmann, M Morgan, B Porse, E Tagliafico, C M Zwaan, J Wainscoat, M M Van den Heuvel-Eibrink, K Mills, L Bullinger, Gene expression profiling in MDS and AML: potential and future avenues, Leukemia, 2011, 25, 6, 909

    CrossRef

  29. You have free access to this content29
    Alice H Berger, Pier Paolo Pandolfi, Haplo-insufficiency: a driving force in cancer, The Journal of Pathology, 2011, 223, 2
  30. 30
    Mrinal M. Patnaik, Terra L. Lasho, Christy M. Finke, Ryan A. Knudson, Rhett P. Ketterling, Dong Chen, James D. Hoyer, Curtis A. Hanson, Ayalew Tefferi, Isolated del(5q) in myeloid malignancies: Clinicopathologic and molecular features in 143 consecutive patients, American Journal of Hematology, 2011, 86, 5
  31. 31
    Benjamin L. Ebert, Molecular Dissection of the 5q Deletion in Myelodysplastic Syndrome, Seminars in Oncology, 2011, 38, 5, 621

    CrossRef

  32. 32
    Joanna Wegrzyn, Jeffrey C. Lam, Aly Karsan, Mouse models of myelodysplastic syndromes, Leukemia Research, 2011, 35, 7, 853

    CrossRef

  33. 33
    Nicholas Burwick, Akiko Shimamura, Johnson M. Liu, Non–Diamond Blackfan Anemia Disorders of Ribosome Function: Shwachman Diamond Syndrome and 5q- Syndrome, Seminars in Hematology, 2011, 48, 2, 136

    CrossRef

  34. 34
    K. A. McGowan, W. W. Pang, R. Bhardwaj, M. G. Perez, J. V. Pluvinage, B. E. Glader, R. Malek, S. M. Mendrysa, I. L. Weissman, C. Y. Park, G. S. Barsh, Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome, Blood, 2011, 118, 13, 3622

    CrossRef

  35. 35
    Rami S. Komrokji, Alan F. List, Role of Lenalidomide in the Treatment of Myelodysplastic Syndromes, Seminars in Oncology, 2011, 38, 5, 648

    CrossRef

  36. 36
    Eric Padron, Rami Komrokji, Alan F. List, The 5q- Syndrome: Biology and Treatment, Current Treatment Options in Oncology, 2011, 12, 4, 354

    CrossRef

  37. 37
    Alzbeta Vasikova, Monika Belickova, Eva Budinska, Jaroslav Cermak, A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome, Leukemia Research, 2010, 34, 12, 1566

    CrossRef

  38. 38
    Jillian L Barlow, Lesley F Drynan, Duncan R Hewett, Luke R Holmes, Silvia Lorenzo-Abalde, Alison L Lane, Helen E Jolin, Richard Pannell, Angela J Middleton, See Heng Wong, Alan J Warren, James S Wainscoat, Jacqueline Boultwood, Andrew N J McKenzie, A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q– syndrome, Nature Medicine, 2010, 16, 1, 59

    CrossRef

  39. 39
    Kais Hussein, Katharina Theophile, Guntram Büsche, Brigitte Schlegelberger, Gudrun Göhring, Hans Kreipe, Oliver Bock, Aberrant microRNA expression pattern in myelodysplastic bone marrow cells, Leukemia Research, 2010, 34, 9, 1169

    CrossRef

  40. 40
    J. Boultwood, A. Pellagatti, A. N. J. McKenzie, J. S. Wainscoat, Advances in the 5q- syndrome, Blood, 2010, 116, 26, 5803

    CrossRef

  41. 41
    Esther N. Oliva, Maria Cuzzola, Francesco Nobile, Francesca Ronco, Maria Grazia D’Errigo, Carmelo Laganà, Fortunato Morabito, Sara Galimberti, Agostino Cortelezzi, Maria A. Aloe Spiriti, Giorgina Specchia, Antonella Poloni, Massimo Breccia, Riccardo Ghio, Carlo Finelli, Pasquale Iacopino, Giuliana Alimena, Roberto Latagliata, Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion, European Journal of Haematology, 2010, 85, 3
  42. 42
    Sean M Post, Alfonso Quintás-Cardama, Closing in on the pathogenesis of the 5q- syndrome, Expert Review of Anticancer Therapy, 2010, 10, 5, 655

    CrossRef

  43. 43
    A Pellagatti, M Cazzola, A Giagounidis, J Perry, L Malcovati, M G Della Porta, M Jädersten, S Killick, A Verma, C J Norbury, E Hellström-Lindberg, J S Wainscoat, J Boultwood, Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells, Leukemia, 2010, 24, 4, 756

    CrossRef

  44. 44
    G.-F. Wu, Y.-L. Hou, W.-R. Hou, Y. Song, T. Zhang, Giant panda ribosomal protein S14: cDNA, genomic sequence cloning, sequence analysis, and overexpression, Genetics and Molecular Research, 2010, 9, 4, 2004

    CrossRef

  45. 45
    J. Wang, A. A. Fernald, J. Anastasi, M. M. Le Beau, Z. Qian, Haploinsufficiency of Apc leads to ineffective hematopoiesis, Blood, 2010, 115, 17, 3481

    CrossRef

  46. 46
    A. Pellagatti, T. Marafioti, J. C. Paterson, J. L. Barlow, L. F. Drynan, A. Giagounidis, S. A. Pileri, M. Cazzola, A. N. J. McKenzie, J. S. Wainscoat, J. Boultwood, Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome, Blood, 2010, 115, 13, 2721

    CrossRef

  47. 47
    Rami S. Komrokji, Alan F. List, Lenalidomide for Treatment of Myelodysplastic Syndromes: Current Status and Future Directions, Hematology/Oncology Clinics of North America, 2010, 24, 2, 377

    CrossRef

  48. 48
    Rami S. Komrokji, Jeffrey E. Lancet, Alan F. List, Lenalidomide in Myelodysplastic Syndromes: An Erythropoiesis-Stimulating Agent or More?, Current Hematologic Malignancy Reports, 2010, 5, 1, 9

    CrossRef

  49. 49
    Charles H. Lawrie, microRNA expression in erythropoiesis and erythroid disorders, British Journal of Haematology, 2010, 150, 2
  50. 50
    Mar Tormo, Isabel Marugán, Marisa Calabuig, Myelodysplastic syndromes: an update on molecular pathology, Clinical and Translational Oncology, 2010, 12, 10, 652

    CrossRef

  51. 51
    Kais Hussein, Katharina Theophile, Guntram Büsche, Brigitte Schlegelberger, Gudrun Göhring, Hans Kreipe, Oliver Bock, Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome, Leukemia Research, 2010, 34, 3, 328

    CrossRef

  52. 52
    S. W. Lane, S. M. Sykes, F. Al-Shahrour, S. Shterental, M. Paktinat, C. Lo Celso, J. L. Jesneck, B. L. Ebert, D. A. Williams, D. G. Gilliland, The Apcmin mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS, Blood, 2010, 115, 17, 3489

    CrossRef

  53. 53
    K M Eisenmann, K J Dykema, S F Matheson, N F Kent, A D DeWard, R A West, R Tibes, K A Furge, A S Alberts, 5q– myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics, Oncogene, 2009, 28, 39, 3429

    CrossRef

  54. 54
    S. Wei, X. Chen, K. Rocha, P. K. Epling-Burnette, J. Y. Djeu, Q. Liu, J. Byrd, L. Sokol, N. Lawrence, R. Pireddu, G. Dewald, A. Williams, J. Maciejewski, A. List, A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide, Proceedings of the National Academy of Sciences, 2009, 106, 31, 12974

    CrossRef

  55. 55
    Naomi Galili, Azra Raza, Clinical implications of gene expression profiling in myelodysplastic syndromes: Recognition of ribosomal and translational gene dysregulation and development of predictive assays, Best Practice & Research Clinical Haematology, 2009, 22, 2, 223

    CrossRef

  56. 56
    B L Ebert, Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer, Leukemia, 2009, 23, 7, 1252

    CrossRef

  57. 57
    Ayalew Tefferi, James W. Vardiman, Myelodysplastic Syndromes, New England Journal of Medicine, 2009, 361, 19, 1872

    CrossRef

  58. You have free access to this content58
    M. Jädersten, E. Hellström-Lindberg, Myelodysplastic syndromes: biology and treatment, Journal of Internal Medicine, 2009, 265, 3
  59. 59
    Judith Neukirchen, Rainer Haas, Ulrich Germing, Prognostic molecular markers in myelodysplastic syndromes, Expert Review of Hematology, 2009, 2, 5, 563

    CrossRef

  60. 60
    K. Sridhar, D. T. Ross, R. Tibshirani, A. J. Butte, P. L. Greenberg, Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression, Blood, 2009, 114, 23, 4847

    CrossRef

  61. 61
    Musaffe Tuna, Sakari Knuutila, Gordon B. Mills, Uniparental disomy in cancer, Trends in Molecular Medicine, 2009, 15, 3, 120

    CrossRef

  62. 62
    Azim Mohamedali, Ghulam J. Mufti, Van-den Berghe’s 5q- syndrome in 2008, British Journal of Haematology, 2009, 144, 2
  63. 63
    Sridhar Srinivasan, Charles A Schiffer, Current treatment options and strategies for myelodysplastic syndromes, Expert Opinion on Pharmacotherapy, 2008, 9, 10, 1667

    CrossRef

  64. 64
    Andrea Pellagatti, Eva Hellström-Lindberg, Aristoteles Giagounidis, Janet Perry, Luca Malcovati, Matteo G. Della Porta, Martin Jädersten, Sally Killick, Carrie Fidler, Mario Cazzola, James S. Wainscoat, Jacqueline Boultwood, Haploinsufficiency of RPS14 in 5q− syndrome is associated with deregulation of ribosomal- and translation-related genes, British Journal of Haematology, 2008, 142, 1
  65. 65
    Jacqueline Boultwood, James S. Wainscoat, Molecular Pathogenesis of the 5q– Syndrome: The Role of RPS14 in Pathogenesis and SPARC in the Hematologic Response to Lenalidomide, Clinical Leukemia, 2008, 2, 3, 182

    CrossRef

  66. 66
    Iya Znoyko, Robert K. Stuart, Tara Ellingham, Jennifer Winters, Daynna J. Wolff, Denise I. Quigley, Tetraploidy and 5q deletion in myelodysplastic syndrome: A case report, Cancer Genetics and Cytogenetics, 2008, 183, 1, 64

    CrossRef

  67. 67
    Naomi Galili, Raymond Cruz, Jamie Stratton, Jessica Clima, Ghulam Sajjad Khan, Azra Raza, A Pluralistic Approach to the Study of Myelodysplastic Syndromes: Evolving Pathology of the Seed via the Soil,
  68. 68
    Myelodysplastic Syndromes,
  69. 69
    The Myelodysplastic Syndromes,